SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001126234-19-000020
Filing Date
2019-02-27
Accepted
2019-02-27 16:41:06
Documents
14
Period of Report
2019-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nlnk-20190227x8k.htm 8-K 25597
2 PRESS RELEASE nlnk-20190227x8kxex991.htm EX-99.1 137137
3 PRESENTATION q42018earningsslidesv6.htm EX-99.2 15619
4 newlogoa21.jpg GRAPHIC 14001
5 q42018earningsslidesv6001.jpg GRAPHIC 135542
6 q42018earningsslidesv6002.jpg GRAPHIC 78627
7 q42018earningsslidesv6003.jpg GRAPHIC 243854
8 q42018earningsslidesv6004.jpg GRAPHIC 113664
9 q42018earningsslidesv6005.jpg GRAPHIC 58112
10 q42018earningsslidesv6006.jpg GRAPHIC 115217
11 q42018earningsslidesv6007.jpg GRAPHIC 105174
12 q42018earningsslidesv6008.jpg GRAPHIC 65284
13 q42018earningsslidesv6009.jpg GRAPHIC 120219
14 q42018earningsslidesv6010.jpg GRAPHIC 25672
  Complete submission text file 0001126234-19-000020.txt   1661910
Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010
Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555
NEWLINK GENETICS CORP (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 19638309
SIC: 2834 Pharmaceutical Preparations